Prostatic Hyperplasia/Cancer

BackgroundBenign prostatic hyperplasia - also called BPH - is a condition in men in which the prostate gland is enlarged and not cancerous. Benign prostatic hyperplasia is also called benign prostatic hypertrophy or benign prostatic obstruction.

Prostate cancer can affect any part of the prostate, but it is usually the lateral lobes, the sides of the prostate, that are affected. In advanced cases, prostate cancer can spread to the bones, but usually only travels to areas within the pelvis.

Model: Spontaneous prostatic hyperplasia in aged monkey by elevated PSA

Standard study duration: 6-12 months

Clinical endpoint: Blood PSA levels; B-ultrasound; Biopsy, histology, and IHC; Targets and biomarkers; Features: BPH, carcinogenesis and the experimental therapeutics, Recurrence following prostatectomy, PSA targeted therapy

Status: Open for Co-development


For more information about these models, please contact Mr. James Song,